ArticleRheumatology and therapy2020

Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE.

Robert Landewé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.